Skip to main content
SpringerLink
Log in

hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Thomas J, Wang L, Clark RE, Pirmohamed M . Active transport of imatinib into and out of cells: implications for drug resistance. Blood 2004; 104: 3739–3745.

    Article  CAS  PubMed  Google Scholar 

  2. Marin D, Bazeos A, Mahon F-X, Eliason L, Milojkovic D, Bua M et al. Adherence is the critical factor for achieving molecular responses in chronic myeloid leukemia patients who achieve complete cytogenetic responses on imatinib. J Clin Oncol; e-pub ahead of print 12 April 2010.

  3. Wang L, Giannoudis A, Lane S, Williamson P, Pirmohamed M, Clark RE . Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia. Clin Pharmacol Ther 2008; 83: 258–264.

    Article  CAS  PubMed  Google Scholar 

  4. Crossman LC, Druker BJ, Deininger MW, Pirmohamed M, Wang L, Clark RE . hOCT 1 and resistance to imatinib. Blood 2005; 106: 1133–1134.

    Article  CAS  PubMed  Google Scholar 

  5. Zhang WW, Cortes JE, Yao H, Zhang L, Reddy NG, Jabbour E et al. Predictors of primary imatinib resistance in chronic myelogenous leukemia are distinct from those in secondary imatinib resistance. J Clin Oncol 2009; 27: 3642–3649.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Gaiger A, Henn T, Horth E, Geissler K, Mitterbauer G, Maier-Dobersberger T et al. Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression. Blood 1995; 86: 2371–2378.

    CAS  PubMed  Google Scholar 

  7. Kim DH, Xu W, Ma C, Liu X, Siminovitch K, Messner HA et al. Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia. Blood 2009; 113: 2517–2525.

    Article  CAS  PubMed  Google Scholar 

  8. Shu Y, Brown C, Castro RA, Shi RJ, Lin ET, Owen RP et al. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin Pharmacol Ther 2008; 83: 273–280.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematology, Imperial College London, Hammersmith Hospital, London, UK

    A Bazeos, D Marin, A G Reid, G Gerrard, D Milojkovic, P C May, H de Lavallade, P Garland, K Rezvani, J F Apperley, J M Goldman, L Foroni & J S Khorashad

Authors
  1. A Bazeos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D Marin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A G Reid
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G Gerrard
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D Milojkovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P C May
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H de Lavallade
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P Garland
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. K Rezvani
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J F Apperley
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. J M Goldman
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. L Foroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. J S Khorashad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J S Khorashad.

Ethics declarations

Competing interests

D Marin, JF Apperley, JM Goldman, D Milojkovic and K Rezvani receive honoraria and/or research funds from Novartis Pharmaceuticals. However, Novartis had no role in the design of the study, collection of the data or the decision to publish.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bazeos, A., Marin, D., Reid, A. et al. hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia. Leukemia 24, 1243–1245 (2010). https://doi.org/10.1038/leu.2010.86

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2010.86

  • Springer Nature Limited

This article is cited by

Search

Navigation